Elevate your expertise in transplantation, cell, and gene therapy from discovery to delivery at #Tandem26. Join us in February 2026 in Salt Lake City to explore breakthroughs, connect with leaders, and move the field forward.

It was a pleasure to present our @CIBMTR Acute Leukemia working committee study on AML with TP53 alteration and outcomes after alloHCT #ASH25 #bmtsm

CMS is proposing a rule change that betrays the vision of President Trump and Dr. Oz for American healthcare and must be stopped. Join us in ensuring access to critical items for Medicare beneficiaries is maintained.

The Tandem Meetings is now accepting late-breaking abstracts and abstracts from federal investigators! Eligible abstracts will be selected for oral presentation. Submit your HCT, cell and gene therapy research findings by Dec. 23: https://t.co/IODff04BfY @CIBMTR

Thank you to everyone who visited CIBMTR’s booth and attended oral and poster abstract sessions during #ASH25! We look forward to seeing you Feb. 4-7, 2026, for #Tandem26!

HOUSING FRAUD ALERT: Attending #Tandem26? Book your 2026 Tandem Meetings housing only through onPeak using the info emailed to you. Ignore third-party offers and never share personal details. Questions? Contact TandemMeetings@mcw.edu.

Great #ASH25 presentation by Robert Soiffer👏 In this large @CIBMTR study of allo-HCT, cryopreservation was associated with: ✅↓ cGVHD overall (but not with PTCy) ⚠️No difference in relapse ⚠️↑ TRM and ↓ OS/DFS These data raise concerns about routine use of cryopreservation.

Great #ASH25 presentation by @MunshiPashnaMD 👏 In HLA-matched MAC allo-HCT, PTCy outperformed CNI/MTX (+/– ATG): ✅ better GRFS ✅ lower acute & chronic GVHD ✅ lower early relapse However, no difference in DFS was observed in this large @CIBMTR study.

Don’t miss CIBMTR at #ASH25! Be sure to attend today’s variety of oral and poster abstract presentations. See a list of presentations, here:  https://t.co/J7VqeWWTVu

Today is the final day to visit CIBMTR’s booth (#782) in the #ASH25 exhibit hall! Make sure to stop by our booth between 10 a.m. and 2 p.m. ET! LAST CHANCE – visit our booth for the opportunity to save on your #Tandem26 registration!

If you’re attending #ASH25 this weekend, make sure to stop by the CIBMTR booth (#782) in the exhibit hall – open between 10 a.m. and 5 p.m. ET! Plus, catch today’s abstract presentations. Below is a snapshot of CIBMTR abstracts being presented today.  https://t.co/J7VqeWWTVu

CIBMTR is exhibiting at #ASH25! Stop by our booth (#782) in the exhibit hall between 11 a.m. and 5 p.m. ET! Plus – visit our booth for the opportunity to save on your #Tandem26 registration!

At #ASH25 this weekend? Make sure to come visit us in the exhibit hall! Located between @nmdp_org and @ASTCT! We look forward to seeing you!

Comparing outcomes between "Frail" and "Non-frail" patient cohorts receiving cilta-cel using CIBMTR database #Outcomes #mmsm #Ciltacel #Fraility #ASH25 @ASH_hematology - Prolonged cytopenias at day +30 more in frail patients (Frail: 30.6% vs Non-frail: 21.2%) - ICANS (all

#ASH25 A CIBMTR analysis of cilta-cel in frail MM patients. Frail patients (n=183) had greater risk of ICANS, and worse PFS and OS vs. non-frail @HiraSMian @MeeraMohanMD @CIBMTR

Attending #ASH25? CIBMTR investigators will present 25+ abstracts, this weekend. Look at today’s abstract presentations below and see the full list on our website!  https://t.co/J7VqeWWTVu

Attending #ASH25 this weekend? If so, make sure to stop by the CIBMTR booth (#782) in the exhibit hall – for a special opportunity to save on your #Tandem26 registration! You can also view a list of all CIBMTR abstracts, here:  https://t.co/J7VqeWWTVu

People with multiple myeloma and their doctors say that there are 6 main obstacles to getting a transplant. Read about this CIBMTR study to learn more: https://t.co/BjuKH5zROy

Have you seen our redesigned Study Summaries webpage? Patient-friendly and easier to navigate! Search by keyword or filter by category to quickly find what you need. Try the new features today!

Don’t miss your chance to secure the lowest registration rates for #Tandem26, Feb 4–7, 2026 in Salt Lake City. Four days to learn, collaborate & advance expertise in HCT, cellular & gene therapy. Register before Dec 6:

This February, take your career to new heights in stunning Salt Lake City at the 2026 Tandem Meetings. Join global leaders in hematopoietic cell transplantation and cellular therapy to explore the future of science, patient care and innovation Feb. 4-7. ⛷️⛰️